Literature DB >> 1279966

The prevalence and prognostic significance of arrhythmias in Duchenne type muscular dystrophy.

A Yanagisawa1, M Miyagawa, M Yotsukura, T Tsuya, C Shirato, T Ishihara, T Aoyagi, K Ishikawa.   

Abstract

To investigate the prevalence and prognostic significance of cardiac arrhythmias in Duchenne type muscular dystrophy 24-hour ambulatory ECG was performed in 80 patients with Duchenne type muscular dystrophy, and they were followed up for 5 years. Various arrhythmias were observed in 63.8% (51 of 80) of the patients. Ventricular premature beats were found in 30% (24 of 80), and the incidence of ventricular premature beats increased as the clinical severity of skeletal muscle involvement advanced. Forty-seven patients survived for 5 years, but the incidence of arrhythmias increased from 38.3% (18 of 47) to 74.5% (35 of 47) (p < 0.001). During the 5-year period, four of 33 deaths were sudden. Malignant ventricular premature beats (ventricular couplets, ventricular tachycardia, and R-on-T-type ventricular premature beats) were observed in three of these four patients. It appears that cardiac arrhythmias are a common complication of Duchenne type muscular dystrophy and that the incidence of ventricular arrhythmias increases with the progression of myocardial involvement. There is an association between ventricular arrhythmias and sudden death, but the reduction of ventricular arrhythmias may not reduce the incidence of episodes of sudden death.

Entities:  

Mesh:

Year:  1992        PMID: 1279966     DOI: 10.1016/0002-8703(92)90407-m

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.

Authors:  Michelle Wehling-Henricks; Maria C Jordan; Tomomi Gotoh; Wayne W Grody; Kenneth P Roos; James G Tidball
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

2.  Predictive value of myocardial delayed enhancement in Duchenne muscular dystrophy.

Authors:  Shaji C Menon; Susan P Etheridge; Kirk N Liesemer; Richard V Williams; Tyler Bardsley; Mason C Heywood; Michael D Puchalski
Journal:  Pediatr Cardiol       Date:  2014-05-15       Impact factor: 1.655

3.  Cardiac Disease Burden and Risk of Mortality in Hospitalized Muscular Dystrophy Patients.

Authors:  Ann R Punnoose; Jonathan R Kaltman; William Pastor; Robert McCarter; Jianping He; Christopher F Spurney
Journal:  Pediatr Cardiol       Date:  2016-06-17       Impact factor: 1.655

4.  Low human dystrophin levels prevent cardiac electrophysiological and structural remodelling in a Duchenne mouse model.

Authors:  Gerard A Marchal; Maaike van Putten; Arie O Verkerk; Simona Casini; Kayleigh Putker; Shirley C M van Amersfoorth; Annemieke Aartsma-Rus; Elisabeth M Lodder; Carol Ann Remme
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

5.  Evaluation of cardiac functions in children with Duchenne Muscular Dystrophy: A prospective case-control study.

Authors:  Abdelrahim Abdrabou Sadek; Shaimaa Mohamed Mahmoud; Mohammed Abd El-Aal; Ahmed Ahmed Allam; Walaa Ibrahim Abd El-Halim
Journal:  Electron Physician       Date:  2017-11-25

Review 6.  Dystrophic Cardiomyopathy-Potential Role of Calcium in Pathogenesis, Treatment and Novel Therapies.

Authors:  Victoria P A Johnstone; Helena M Viola; Livia C Hool
Journal:  Genes (Basel)       Date:  2017-03-24       Impact factor: 4.096

7.  Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy.

Authors:  Yusuke Echigoya; Akinori Nakamura; Tetsuya Nagata; Nobuyuki Urasawa; Kenji Rowel Q Lim; Nhu Trieu; Dharminder Panesar; Mutsuki Kuraoka; Hong M Moulton; Takashi Saito; Yoshitsugu Aoki; Patrick Iversen; Peter Sazani; Ryszard Kole; Rika Maruyama; Terry Partridge; Shin'ichi Takeda; Toshifumi Yokota
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-03       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.